Washington: Researchers have found that therapy with cardiopoietic (cardiogenically-instructed) or "smart" stem cells can improve heart health for people suffering from heart failure.This is the first application in patients of lineage-guided stem cells for targeted regeneration of a failing organ, paving the way to development of next generation regenerative medicine solutions.The multi-center, randomized Cardiopoietic stem cell therapy in heart failure (C-CURE) trial involved heart failure patients from Belgium, Switzerland and Serbia.Patients in the control group received standard care for heart failure in accordance with established guidelines. Patients in the cell therapy arm received, in addition to standard care, cardiopoietic stem cells - a first-in-class biotherapeutic. In this process, bone marrow was harvested from the top of the patient`s hip, and isolated stem cells were treated with a protein cocktail to replicate natural cues of heart development.
Pune blast: ATS tracking online chats of IM terrorists
Devotees throng Mathura on the occassion of Guru Purnima
Shirdi Sai Baba is not God or Guru, says Shankaracharya
UPSC aspirants protest outside Rajnath Singh`s residence